Based on our findings, we conclude that myofibroblast-derived CRC, TNS1, and FERMT2 orchestrate tumour progression by upregulating FN1, which subsequently activates integrin and FAK signaling in cancer cells (Fig. 7g). Here, PTK2 is linked to neoplasm.